The mission of the ISPE Singapore Affiliate is to develop an active events calendar and provide education and training services in Singapore and South East Asia for pharmaceuticals manufacture and GMP compliance.
The mission of the ISPE Singapore Affiliate is to develop an active events calendar and provide education and training services in Singapore and South East Asia for pharmaceuticals manufacture and GMP compliance.
PIC/s Annex 1, and the WHO Annex 2 for the manufacturing of sterile products took effect on 25 August 2023, and the time to attend the 2023 ISPE Pharma 4.0™ and Annex 1...
ISPE is proud to introduce two significant initiatives aimed at benefitting the field of pharmaceutical compounding—the release of the "ISPE Guide: 503B Compounding –...
The pharmaceutical industry is constantly evolving, placing a significant emphasis on emerging technologies that facilitate quicker access of medications for patients globally...
WEBINAR: Mastering Quality Control: The Power of FT-IR/NIR and Raman Spectroscopy for Pharmacopeia Compliance 29 Sep 2023 3.00-4.30pm SGT | Online Sponsored by: Topic...
ISPE Singapore Quiz Night 2023 21 Sep 2023 | 6-8.30pm | Venue: Café Melba at Mediapolis Meet old and make new friends over dinner & drinks, test your local and general...
Introducing the Future of ISPE Guidance Documents At ISPE, our mission has always been to connect knowledge, operational excellence and regulatory insights. In keeping with this commitment, we are excited to announce...
The 2023 ISPE Biotechnology Conference in Dublin from 26-27 June 2023, provided both in-person and virtual attendees an overall view of the development and manufacturing of biotechnology products. For current biotech...
Thank you to the program committee, speakers, attendees and all those involved for a successful 2023 ISPE Europe Annual Conference! See you next year in Lisbon, Portugal! The 6 main tracks at this conference were...
Shortages of essential medicines around the world have been an ongoing concern for patients, caregivers, and regulators and have been exacerbated by the COVID-19 pandemic. Many regulators have instituted requirements for reporting potential or actual...